Volume 29, Issue 6 pp. 936-948
ORIGINAL ARTICLE
Free Access

Family storytelling about hereditary cancer: Framing shared understandings of risk

Gemme Campbell-Salome

Corresponding Author

Gemme Campbell-Salome

Genomic Medicine Institute, Geisinger, Danville, PA, USA

Correspondence

Gemme Campbell-Salome, Genomic Medicine Institute, Geisinger, Danville, PA 17822.

Email: [email protected]

Search for more papers by this author
Emily A. Rauscher

Emily A. Rauscher

Department of Communication, University of Utah, Salt Lake City, UT, USA

Search for more papers by this author
First published: 22 January 2020
Citations: 11

Abstract

Family communication about the family's health history (FHH) is an important step in alerting individuals to their hereditary disease risks and facilitating prevention. Individuals often communicate about the FHH of hereditary cancer as a story, which highlights the importance of analyzing family narratives of hereditary cancer to better understand their relation to psychological and physical well-being. This study investigates the content of family stories by examining how narrative tone and framing relate to coping, perceptions of risk, and medical decision-making. The current study recruited 42 family dyads with a prevalent FHH of hereditary cancer to participate in dyadic phone interviews to jointly tell their family narrative of hereditary cancer. Using an iterative analysis, findings examine how families create a shared understanding of FHH and hereditary risk. Narrative tone reflects participants' psychological well-being and contributed to the way families framed their experiences. Common frames to family narratives of hereditary cancer included empowerment, adversity, laissez faire, and discrepant. Each frame gave insight into how families were coping, their perceptions of risk, and how they make medical decisions to manage those risks. Developing a better understanding of how families communicate about their hereditary cancer risks can aid in designing clinical interventions to help families re-frame their stories to promote improved health outcomes.

1 INTRODUCTION

Family communication about the family's health history (FHH) is an important first step in becoming aware of and managing health risks for individuals with pathogenic gene variants, which put them at an increased lifelong risk for hereditary disease. Thus, special attention needs to be given to how families are communicating about this topic and influencing individuals’ medical decision-making. Although much research focuses on how family members share or block genetic disease risk information (Forrest et al., 2003; Koehly et al., 2009), less research examines the persistent influence family communication exercises on health attitudes and behaviors for hereditary cancer risks.

To date, more than 50 hereditary cancer syndromes have been identified for which individuals can test (NCI, 2013). Currently, research is flourishing in diagnosis, prevention, and treatment among common hereditary cancers such as Lynch syndrome, hereditary breast and ovarian cancer (HBOC) syndrome, and Li–Fraumeni syndrome (LFS). Individuals diagnosed with Lynch syndrome, also commonly called hereditary nonpolyposis colorectal cancer (HNPCC), have a 52%–82% risk of developing colorectal cancer, a 25%–60% risk of developing endometrial cancer, a 6%–13% risk of developing gastric cancer, and a 4%–12% risk of developing ovarian cancer over their lifetime (Kohlmann & Gruber, 2014). Further, these individuals are also at risk for other Lynch-related cancers such as stomach, hepatobiliary tract, urinary tract, small bowel, brain/central nervous system, and sebaceous neoplasms (Lindor et al., 2006). Lynch syndrome is associated with pathogenic variants in genes including MLH1, MSH2, MSH6, PMS2, and EPCAM (Baglietto et al., 2010; Kohlmann & Gruber, 2014).

In the case of HBOC, pathogenic variants in BRCA1/2 account for approximately 25% of HBOC cases, which currently makes them the most prevalent (Nielsen, van Overeem Hansen, & Sorensen, 2016). Women who inherit a BRCA1 gene variant have a 55%–65% risk of developing breast cancer, 44% risk of developing ovarian cancer, and a 3.3% risk of developing pancreatic cancer over their lifetime (Antoniou et al., 2003; Cavanagh & Rogers, 2015; Kuchenbaecker et al., 2017). Women who inherit a BRCA2 gene variant have a 45% chance of developing breast cancer, a 17% risk of developing ovarian cancer, and a 6.6% risk of developing pancreatic cancer over their lifetime (Antoniou et al., 2003; Cavanagh & Rogers, 2015; Iqbal et al., 2012; Kuchenbaecker et al., 2017). Men with a pathogenic variant in BRCA1/2 are at an increased risk of developing breast cancer, pancreatic cancer, prostate cancer, and melanoma (Cavanagh & Rogers, 2015; Lecarpentier et al., 2017; Mahon, 2014). However, men's risks for developing these cancers are much lower than women who a BRCA1/2 gene variant. Recently, there have been additional pathogenic variants in genes identified for HBOC including CHEK2, NBS1, ATM, BRIPI, and PALB2 (Kluska et al., 2017).

Less risk information is known for LFS, but cancers associated with an LFS diagnosis include breast cancer, osteosarcoma, soft tissue sarcomas, brain tumors, leukemias, and adrenocortical carcinoma (NIH, 2019). Pathogenic variants in genes including CHEK2 and TP53 are associated with LFS. Finally, men and women with gene variants related to these cancer syndromes have a 50% chance of passing on the variant and inherited risks to their offspring (NCI, 2017). Family communication about FHH can alert individuals to their risks and facilitate prevention (Ashida, Kaphingst, Goodman, & Schafer, 2013). Currently across these hereditary cancer syndromes, advanced screenings and prophylactic surgeries are recommended in addition to lifestyle changes related to diet, exercise, and smoking cessation (Kohlmann & Gruber, 2014; Kratz et al., 2017; Petrucelli, Daly, & Feldman, 2013). Thus, an individual's hereditary risk status carries serious implications for close relatives (Sobel & Cowan, 2003), which makes family communication an important area of research.

One way families communicate to disseminate and make sense of FHH is through multigenerational family narratives (Werner-Lin & Gardener, 2009). For the purposes of this study, we refer to narratives as the larger set of family stories that reflect the family's culture and shared understanding, whereas stories are individually told accounts that when brought together contribute to the family narrative (Koenig Kellas & Trees, 2005). Telling stories can help family members make sense of and cope with their difficult health experiences (Trees, Koenig Kellas, & Roche, 2010). For example, previous research on family stories has established links between narratives and mental health, family functioning, and physical health (Harter, and Hayward, 2010; Koenig Kellas & Trees, 2006; Koenig Kellas, Trees, Schrodt, LeClair-Underberg, & Willer, 2010). Hereditary cancer and family members’ experiences with hereditary cancers may become a focal point of family narratives, defining how individuals come to understand their risks and make medical decisions. As discussions of genetics often inherently involve family, a focus on how families manage hereditary cancer risks communally can contribute to developing strategies motivating patients to share genetic risk information with relatives and make informed medical decisions (Parrott & Hong, 2014). Indeed, knowledge of the family's medical history is associated with engagement in exercise, healthy diet, participation in screenings, and losing weight, and can inform practitioners’ recommendations for screening and prevention (Baptiste-Roberts et al., 2007).

As individuals face difficult life events such as losing family members from multiple generations to hereditary cancer or facing hereditary cancer risks, they process, make sense of, and cope with these challenging situations through storytelling (Koenig Kellas, 2018). Guided by communicated narrative sense-making (CNSM), this study explores the content of family stories about hereditary cancer to examine how narrative content may relate to coping, perceptions of risk, and medical decision-making. The relationships among narrative content and coping, perceptions of risk, and medical decision-making are complex and mutually influencing. These outcomes also likely influence the stories families share. CNSM is a useful theory for examining family narratives, as it defines patterns of narrative construction such as tone and framing, which can be connected to psychosocial, psychological, and health outcomes (Koenig Kellas, 2018).

Narrative tone reflects the emotional expression of the overall story and indicates how the individual is emotionally processing events in the story (McAdams, Reynolds, Lewis, & Bowman, 2001). Especially, narrative tone can represent the storyteller's core beliefs about the world (McAdams et al., 2001), including if they see their likelihood of developing cancer as inevitable due to the FHH of hereditary cancer. Feeling cancer is inevitable can transfer into the family narrative through the use of tone and influence how families share risk information, which may affect members’ ability to cope with their risks (Kenen, Ardern-Jones, & Eeles, 2003). Tone also contributes to the overall frame of the family cancer narrative.

Narrative framing is how emotion progresses through the course of the story to develop an overall emotional sequence (Koenig Kellas, 2018). Individuals may construct stories in sequences, which are framed as positive or negative. Although narrative frames can be defined as categories, framing is also something that individuals do when telling stories even if they do not recognize the action (Entman, 1993; Kellermann, 1992). For instance, McAdams et al. (2001) found when families framed their stories of difficulty as redemptive, when a story of difficulty turns into one of positive learning and recovery, family members had improved self-reported measures of life satisfaction, self-esteem, and less depression. Narrative frame can reveal risk perceptions as family members may frame their hereditary cancer experience as positive or negative based on their perceived likelihood of developing cancer and their degree of control over their health. Using the narrative content structures of tone and framing from CNSM, the following research question guided the present study: How do the narrative structures of tone and framing relate to how families cope, perceive their risks, and make medical decisions?

2 METHODS

2.1 Participants

Upon receiving IRB approval, this study used purposive and snowball sampling to recruit subjects who have a prevalent FHH of hereditary cancer (Creswell, 2007; Merriam, 2014). According to the National Cancer Institute (2013), an individual has a prevalent FHH of hereditary cancer if she/he has three or more relatives with specific types of cancer that seem to be inherited (especially early onset) or if an individual has cancer at an early age (especially multiple forms of cancer in the same person). A prevalent history also includes a known pathogenic gene variant in a cancer susceptibility gene within the family (NCI, 2013). Subjects were recruited through advocacy organizations that aim to bring people with hereditary cancer together for informational and support purposes such as FORCE (Facing Our Risk of Cancer Empowerment), Bright Pink, Lynch Syndrome International, Colon Cancer Alliance for Research and Education for Lynch Syndrome, and Li–Fraumeni Syndrome Family and Friends Support Group. These advocacy groups shared recruitment information about the study on their social media pages. Further, subjects were also recruited from the 7th Annual HBOC Patient Conference at the Baylor College of Medicine Medical Center in Houston, Texas, and the 11th Annual FORCE Conference in San Diego, California. As part of recruitment, participants were asked to recruit a family member to participate in the study with them. Recruited family members were not required to be at-risk. Overall, 42 family dyads completed joint phone interviews and follow-up surveys. For participant descriptions, see Table 1.

Table 1. Characteristics of study participants, 42 dyads (84 participants)
1. Age 18–76 years (M = 46.13, SD = 13.88)  
2. Sex Male (N = 21)  
Female (N = 63)  
3. Race Caucasian (89.30%)  
Hispanic (8.3%)  
Asian (1.2%)  
Middle eastern (1.2%)  
4. Dyads Husband–wife (N = 12) Mother–daughter (N = 9)
Father–daughter (N = 5) Mother–Son (N = 1)
Father–son (N = 1) Sisters (N = 7)
Twin sisters (N = 2) Brother–sister (N = 1)
Aunt–niece (N = 2) Cousins (N = 1)
Fictive kin (N = 1)  
5. Annual household income >$25,000 (7.10%)  
$25–50,000 (13.10%)  
$50–75,000 (14.30%)  
$75–100,000 (11.90%)  
<$100,00 (38.10%)  
Prefer not to answer (4.80%)  
6. Education level Graduated high school/GED (6%)  
Some college (14.50%)  
Associate's degree (12%)  
Bachelor's degree (25.30%)  
Graduate/professional degree (37.30%)  
Prefer not to answer (4.80%)  
7. Genetically tested Yes (N = 67)  
No (N = 17)  
8. Pathogenic gene variants NBN (N = 1) BRCA1 (N = 14)
BRCA2 (N = 11) PALB2 (N = 1)
TP53 (N = 4) CHEK2 (N = 3)
EPCAM (N = 11) PMS2 (N = 4)
MSH6 (N = 5) MLH1(N = 3)
9. Hereditary cancer syndrome HBOC (21 dyads)  
Lynch syndrome (19 dyads)  
LFS (2 dyads)  
10. History of cancers Breast Fallopian tube
Endometrial Uterine
Ovarian Prostate
Colon Bladder
Melanoma Squamous cell carcinoma
Adrenal Rectal
11. Time since diagnosis 2–240 months (M = 87.72, SD = 70.97)  
  • a 10 participants reported having more than 1 type of these cancers in their personal health history.

2.2 Procedures

In-depth phone interviews were conducted in a semi-structured format beginning with the prompt, ‘Please tell the story of your family's experience with hereditary cancer, and try to tell it to me as if I’m a family member who does not know much about this history’. Answers to this question helped establish that participants had a prevalent FHH of hereditary cancer and encouraged dyads to share the family narrative of hereditary cancer. When applicable, dyads were asked to tell a story that they may have told together at some point to increase ecological validity (Koenig Kellas & Trees, 2005). Thus, open-ended questions were constructed to capture FHH information in a story format. Probing questions supported a conversational yet structured interview with family dyads. Interviews were audio-recorded and transcribed, lasting an average of 38 min. All interviews were de-identified, and pseudonyms are used to protect participants’ privacy. At the end of interviews, participants were debriefed and thanked for their participation. Upon completion of the family interview, each member of the dyad was sent a link to an online follow-up survey to answer demographic questions. Upon completion of the survey, each family member received a $20 Amazon Gift Card. Data collection ended upon reaching theoretical saturation, in which participant interviews provided rich contributions to the research goals of the study and responses became similar with no new or emergent data (Tracy, 2013). Interviews were conducted between April 2018 and November 2018.

2.3 Data analysis

As this study focuses on narrative content of family stories on hereditary cancer, data were analyzed qualitatively using a phronetic iterative approach that alternated repeatedly between emergent data and past research (Tracy, 2012). This inductive approach refined analysis over time to narrow explications and situate findings in the current literature (Ellingson 2013). Using previous research in the CNSM tradition, narrative tone and framing were used as sensitizing constructs for analysis (Koenig Kellas & Trees, 2005; Kranstuber Horstman et al., 2016). The goal of this data analysis was to provide rich descriptions of overarching themes in tone and frame without fracturing family narrative accounts (Riessman, 2008). By examining themes and trends, this study explicates how narrative tone and frame relate to and reflect coping, perceptions of risks, and medical decision-making. This approach worked well for discovering how narrative tone contributed to framing, defining themes among frames, and examining trends between frames and outcomes.

Open coding began by journaling initial thoughts regarding emerging themes, prevalent family storytelling behaviors, and health outcomes after interviews (Tracy, 2012). After all interviews were transcribed, the researchers both read and listened to dyadic family interviews again to identify first-level themes related to how families were emotionally expressing tone and framing their narratives (Tracy, 2013). First, the content of family stories was coded for the degree to which participants expressed positive or negative affect. For instance, a story that had a higher degree of negative affect was defined as one with a negative feel, in which participants expressed negative emotions such as crying or yelling while jointly telling their stories. Stories with a higher degree of positive affect were defined by content that was cheerful, in which participants were laughing or upbeat during interaction. Next, using definitions of frames as the emotional sequence of a narrative, stories were initially coded for positive and negative framing (Kranstuber Horstman et al., 2016). Definitions of positive and negative frames include redemptive sequences—stories that end on a positive or hopeful note; contamination sequences—stories in which a storyteller may begin positive, but the story concludes in a negative light; and ambivalent—stories that are neither redemptive nor contaminated (Koenig Kellas, 2018; Kranstuber Horstman et al., 2016). Although these definitions were used to classify narratives during first-level coding, these frame categories from previous research did not adequately fit the emergent data. This moved analysis into second-level coding to develop and refine more nuanced framing categories that best fit the empirical data.

Guided by Owen’s (1984) criteria for thematic interpretation in data analysis, emergent themes in second-level coding were recurrent, repetitious, and forceful. Thus, second-level coding led to the development of the emergent framing categories of empowerment, adversity, laissez faire, and discrepant. Through constant comparison between sensitizing constructs from CNSM and the emergent data, the researchers ensured these second-level codes fit the data and were representative of family narratives of hereditary cancer within and across interviews (Charmaz, 2014). Definitions of the emergent framing themes lead to the development of a codebook to manage data and keep analysis consistent for this study (Ryan & Bernard, 2003). Further, in examining prevalent second-level codes for frames among dyadic interviews, the researchers also identified patterns between the ways in which families were framing their narrative and psychological and physical outcomes. Based on these patterns, the researchers added a third level of axial coding to examine how overarching frames such as empowerment, adversity, laissez faire, and discrepant reflected how families were coping, making sense of risk, and making medical decisions (Saldana, 2015).

3 RESULTS

Results illustrate how family members use narrative tone and framing during storytelling about their hereditary cancer experiences. Further, this study draws connections among the narrative tone and frames families use that may shape and be shaped by how individuals cope, perceive their risks, and make medical decisions. Common frame categories included empowerment, adversity, laissez faire, and discrepant. Each frame can both relate to and reflect how the family is coping, understanding risks, and making medical choices to manage their hereditary cancer syndrome.

3.1 Empowerment

Families engaging in the empowerment frame tended to stress how knowledge about their family history of hereditary cancer gave them power and a sense of control over their risks, which helped them to better cope with their diagnosis. In this study, all families engaging in the empowerment frame had at least one family member in the dyad with an identified pathogenic gene variant. Having this specific diagnosis may have afforded these families more clarity about their risks and recommended next steps, possibly facilitating their use of the empowerment frame. Families using the empowerment frame often spoke about becoming their own advocates to make sure they were getting necessary screenings and helping educate family members about their own risks. For example, Susan (mother, 58, BRCA2) and Charlette (daughter, 33, BRCA2) talked about how knowing about their risks and being proactive helped them cope better:

  • Susan:
  • There's the good thing about knowing, obviously, in the knowledge that we have to be able to go out and research the different treatments and screenings that are available, and to find those care providers that are specific in just the BRCA gene. To be proactive with your screening is how I found that not only did I have the genes, but then discovered that I had a very aggressive tumor. We would never have known if we did not have genetic counseling.
  • Charlette:
  • My response would be pretty similar. Just knowing that you have it, I feel like it's more than half of the battle because it's not something that I think about every day. But I am glad that we have doctors that are looking out for us and are very knowledgeable with the topic and are constantly keeping up with new research. Just knowing that I'm being screened and that there are preventative measures that we can take to decrease the risk is helpful.
  • In this example, Susan feels conflicted because the diagnosis of a BRCA2 gene variant and her cancer diagnosis were emotionally difficult, but having answers about her hereditary condition and having the ability to be proactive reflect more positive emotions and better coping. Overall, Susan and Charlette's narrative had positive narrative tone, which created the empowerment frame. This frame reflects family members’ motivation to get genetic testing, pursue preventive care, and find doctors they feel suit their needs. Indeed, both Susan and Charlette pursued genetic testing immediately upon their doctor's recommendation. Charlette also said she pursued preimplantation genetic diagnosis to eliminate future risks for her children. Susan and Charlette's narrative focuses on knowledge and being proactive, which was present in all family narratives within the empowerment frame.

    Finally, beyond knowing about gene variants and having preventive options in general, many family members said they felt empowered by overcoming cancer and becoming an advocate in their family for sharing risk information. For instance, Casey (32, sister, EPCAM) said to Laura (32, sister, EPCAM) that she was glad she got cancer and feels she saved Laura's life:

  • Casey:
  • I think that there's going to be some anxiety involved. I have a little PTSD every year when I wake up for my scope being like, ‘Oh my God, are they going to find something?’ Because the first time I ever had one they found something. I think it's just like you need to be your own advocate and make sure that you're getting the testing.
  • Laura:
  • I think being really proactive about testing and knowing the hand we were dealt-
  • Casey:
  • I know it's frustrating for me when family members don't take that approach. I want to do something about this. I want to be proactive and look for it and get screened appropriately or get tested. I'm like, ‘What's wrong with you? This isn't a death sentence’. I remember telling my mom one time, not that I'm glad I had cancer, but if somebody had to have it among our siblings, I'm glad it was me because I'd already had my kids. Financially and local support, [my husband and I] were probably in the best position to have people help us. Me finding out probably it's like, it saved Laura's life because she could have had another kid, been pregnant and had no idea.
  • In this example, the frame Casey and Laura use echoes the importance of becoming your own advocate and getting informed to better manage health risks. While she and her sister feel anxiety about when they might get cancer, their narrative tone overall is positive because they focus on being proactive and taking control in the face of that anxiety. Moreover, not framing this condition as a death sentence reflects their perceptions of risk for Lynch syndrome. While this condition increases their risks of developing a Lynch-related cancer, it does not mean that they will die, especially if they manage their risks through prevention. Casey followed her doctor's recommendations to undergo a proctocolectomy and a prophylactic hysterectomy after receiving her colorectal cancer and Lynch syndrome diagnoses. After Casey's genetic test results and surgeries, Laura chose to undergo genetic testing. Near the end of their story, both Casey and Laura agree that they are lucky to get a Lynch syndrome diagnosis because with their preventive screening options available, they feel ‘better off than the general population’. Casey goes further by framing her colon and endometrial cancer experiences as something positive for the family since she was able to alert her sister and other members to their risks. Among family narratives in the empowerment frame category, dyads stories focused on improving knowledge, being proactive, and focusing on positive emotions such as gratitude. Although these family narratives often started with negative emotions such as anxiety, shock, and fear, dyads reached a turning point in their narratives in which family members discussed feeling in control of risks by being proactive.

    3.2 Adversity

    Families using an adversity frame told stories about how their perceptions of risks (a) caused intrusive thoughts about developing cancer and (b) had ruined their lives. These families expressed their difficulty in coping with their lifetime hereditary cancer risks and often felt overwhelmed by anxiety, which motivated family dyads to be proactive or avoidant in managing their risks. Families telling stories fitting the adversity frame had often watched generations of family members suffer or die due to hereditary cancer, which made the risks of developing a life-threatening cancer seem almost inevitable.

    Feeling that a cancer diagnosis was certain, even if participants were engaging in preventive screening and prophylactic surgeries, often made at-risk family members within this frame feel helpless in controlling their risks and caused intrusive thoughts. For example, both Paige (sister, 48, TP53) and Nancy (sister, 40, negative for gene variant) felt certain that they were going to get cancer, but when Paige lost her daughter and found out she had LFS, it increased their anxiety:

  • Paige:
  • I think, for me, cancer wasn't anything surprising, and I knew I was always going to get cancer. I just had that feeling, and I ended up getting cancer, a breast cancer, in 2013. I elected to have double mastectomy, which is probably the best decision I could have made because last year my daughter, who was 29, was diagnosed with stage four sarcoma. She passed away 10 weeks later. That's when we found out we had the genetic mutation, and my immediate family basically got tested.
  • Nancy:
  • Just to pick up on some of the things that Paige said. She said that we have a lot of history on both sides of the family. I always felt the same way she did. I haven't had any cancer, but I always feel like, and I still feel like, even though now that I know that a lot of the cancer in my family was caused by this Li-Fraumeni syndrome I still feel like it's probably inevitable that I might get some sort of cancer at some point in my life.
  • Due to their FHH, Nancy and Paige have experienced intrusive thoughts about their risks of cancer, which was why Paige chose to have a double mastectomy to reduce her risks of a breast cancer reoccurrence. As Paige shares her family story of hereditary cancer, the narrative tone is very serious and melancholy with Paige crying while explaining what happened to her daughter. Family narratives in the adversity frame category all used negative affect in tone during storytelling. Nancy said she too feels the threat of cancer is inevitable even though she does not have a gene variant for LFS, which also shows she is still experiencing intrusive thoughts about cancer with a negative result. This frame reflects some family members’ motivation to make proactive medical choices to improve their chances of catching cancer early. Family stories using this frame all included discussions of difficulty emotionally coping with future risks. Families using the adversity frame discussed feeling worried about their risks, their relatives’ risks, and who else they might lose to cancer. Although some using the adversity frame still make proactive medical choices motivated by these negative emotions, others fitting the adversity frame category were avoidant in their medical decision-making.

    Beyond experiencing intrusive thoughts, some families using an adversity frame frequently discussed the feeling that cancer was consuming and ruining their lives. The feelings this frame reflects are why some family members put off genetic testing or other medical decisions related to managing hereditary cancer risks. For example, Nicole (niece, 50, not yet tested) and Beth (aunt, 68, variant of uncertain significance) have relatives with Lynch syndrome along with a prevalent FHH of breast and endometrial cancers. However, Nicole did not want to get genetic testing though she had ovarian and colon cancer diagnoses at a young age because she could not bear dealing with more cancer worry:

  • Beth:
  • When you had your colon cancer diagnosis, I think you had a discussion with the doctor about getting genetic testing. I remember at that point he was pretty sure that you probably had some types of hereditary cancer given your history.
  • Nicole:
  • At some point, there was some discussion about there being a genetic link given the family history and the type of cancer. They talked to me about doing some genetic testing. Some extended family had gotten genetic testing done and there was mention of Lynch syndrome. They talked to me about that specifically and about my feelings about testing and I asked, ‘What would be the pros of that? What would be some other reasons that that would be helpful to me?’ They talked about, well, then we could do screeners to look for additional cancers within that syndrome. I decided not to do it because I felt like I didn't want cancer to just be this all-consuming thing where I'm constantly screening for cancer. I've noticed some symptoms in myself, it was like post-traumatic stress and so just having to really work through that to kind of begin to feel safe again and feel okay, so that when my body is feeling some little twerk, I'm not like, ‘Oh my gosh, what's going on?’ I just felt like the screening, that whole process was going to lead to cancer being this all-consuming thing, and it's constantly going to be a part of my life.
  • Because she perceives the outcome of the genetic testing results will be difficult to cope with, Nicole is motivated to avoid genetic testing although she knows other family members have Lynch syndrome. The tone throughout their family narrative is quite negative and highly emotional. The tone and frame throughout Nicole and Beth's hereditary cancer narrative demonstrate how too much fear and a lack of feeling able to cope prompted Nicole to avoid information about her risks and limits her ability to engage in prevention methods. Similarly, other family dyads fitting into the adversity frame category also discussed avoiding information about their risks by stressing how much cancer ruined lives and how the fear was overwhelming. Feeling overwhelmed and choosing to be avoidant of information limited these family dyads’ ability to make proactive medical decisions. One aspect that Nicole does not verbally connect in her story, similar to other family dyads using the adversity frame, is that even if she is not aware of her hereditary cancer risks, if she is positive for Lynch syndrome there is a high likelihood that more cancers will occur or reoccur even if she continues to avoid the information. Overall, families using an adversity frame had negative emotional tone throughout their stories, in which they were either motivated by anxiety to be proactive or their anxiety was so overwhelming that they became avoidant of hereditary cancer risk information.

    3.3 Laissez faire

    The third frame category that emerged during family narratives was a laissez-faire frame, in which participants were not emotionally involved with their diagnosis and were often misinformed about their risks. Family dyads fitting this frame category showed an unemotional narrative tone and had an ‘it is what it is’ attitude of unemotional acceptance. For instance, Amy (daughter, 24, FHH of Lynch) discussed this attitude with Melissa (mother, 53, FHH of Lynch) of not worrying about her risk status:

  • Amy:
  • It's like I said before. I think it's just one of those things that we've come to the conclusion that [cancer is] either going to happen or not. I think it's just something that we have just accepted. We don't really talk about it much. I talk to my mom about it sometimes. It's hard to explain. It's not something that we're necessarily scared of. It's just like, ‘Okay, how do you go forward and what do you do now or what's the treatment?’ Also me and my siblings personally none of us do anything healthy. [chuckles]
  • Melissa:
  • That's a bit smart. We can laugh about it, which is more socially acceptable than walking around crying. Even though we do laugh about it, we do talk about it. Again, I definitely, I think that's a little shallow, but at least we're still talking.
  • Amy's attitude about possibly getting cancer or having a pathogenic gene variant was that there is not much she can do to change that fate, so she unemotionally accepts it. Although she talks about thinking about next steps, she and her mother later talk about her reluctance to go to the doctor or follow up with screening appointments. Further, Melissa discusses the family's attitude toward their FHH is to laugh about it and make jokes to avoid the emotional pieces of that history. Melissa also notes that they do discuss this topic, but that their talks are shallow, and members are not sharing much information with each other about the FHH or what they should be doing to manage their personal risks. Fitting with the laissez-faire frame, Amy and Melissa were not motivated to become more active in managing their risks. This example reflects the unemotional acceptance and information avoidance of families using the laissez-faire frame. Interestingly, families using this frame did not experience hereditary cancers in their immediate family and often discussed putting off testing or avoiding risk information.

    Using a laissez-faire frame can be especially problematic in parent–child dyads because not only is the parent not necessarily being proactive about their hereditary cancer risks, but also the next generation may be matching this behavior. For instance, when Steven (father, 62, BRCA2) discussed his health decisions and risks with Ashley (daughter, 22, not yet tested), she repeated what he said while explaining why she does not want to get tested at the recommended age of 25:

  • Steven:
  • I like the idea that I can just take care of myself on my own. So I feel like, what would I be doing differently knowing [my genetic testing results]? This is before I got tested and I didn't think that I really would do anything differently. I wasn't worried. I remember, I was concerned about my kids. I just feel like that was the reason why I got tested. I thought, ‘Oh okay, well, maybe instead of them figuring out for themselves at some certain time, let me get tested, and if I'm negative, then they don't have to think about doing it’. My oldest did get tested and she was negative, but none of my other kids have gotten tested yet.
  • Ashley:
  • The woman that tested my dad recommends like, ‘She's young. There's no reason she should get tested now. If she wants to, she could get tested in mid to late 20s, but now there really wouldn't be a point to it’. Also, with that, my dad was saying now like, just again, will this make a difference in my life? For now, I don't think I'm going to get tested. Maybe, one day I'll want to, if I end up having children, then I want to know. Maybe, that will be a reason for it. I'm not in a rush to do it, but I'm also not against it. For now, I don't think I'll get tested.
  • Ashley used the same frame and tone as her father when discussing why she wants to wait on getting tested. This was characteristic of other parent–child dyads across frame categories except discrepant, with adult children often mirroring and reinforcing their parent's story in their responses. Ashley and her father feel that finding out they have a pathogenic BRCA2 variant should not change how they are currently managing their health. Similar to other dyads using the laissez-faire frame, Steven and Ashley's narrative does not reflect motivation to engage in preventive screenings and justifies Ashley's decision to continue putting off genetic testing. Indeed, both Steven and Ashley are unemotionally accepting of their BRCA2 risks. What is problematic about using this frame and tone is that Steven's HBOC-related cancer risks as a man are less serious than Ashley's potential risks if she also has a BRCA2 gene variant. Thus, to not get tested or to wait until later in life when she has children to get tested could be a risky decision as Ashley will not be engaging in preventive screenings such as mammograms and MRIs or considering prophylactic surgeries to prevent cancer if she does have the gene variant. Further, Ashley seems somewhat indecisive about testing, which may suggest that this type of storytelling does not facilitate an accurate assessment of her risks. Other factors related to being at risk for a BRCA2 result likely influence Ashley's decision even though this story emphasizes inaction and emotional distance. As this story is coconstructed, Ashley may be feeling pressure to match her father's narrative by not bringing in other views or considerations, which can limit how the family makes sense of their risks. Overall, families using the laissez-faire frame tended to share inaccurate risk information or had important information related to risk and medical decision-making missing. Throughout these narratives, family members were not emotional when telling their story, and had an attitude of acceptance that their diagnosis would not change anything for them.

    3.4 Discrepant

    Finally, other family dyads were telling the same overall story but used discrepant narrative frames and tones throughout the telling, making comments indicating they did not agree on the story's tone and frame. Using discrepant frames revealed some conflict among family members such as trying to get a family member to take their risks more seriously or encouraging avoidant family members to more proactively manage their risks. Indeed, family dyads with discrepant frames most often had a member using a laissez-faire frame to remain unemotional, while the other talked about feeling strong emotions in managing hereditary cancer risks fitting the adversity or empowerment frame categories. For example, when Hannah (sister, 29, BRCA1) discussed her risks, she used a laissez-faire frame, but pressure from Helen (sister, 34, BRCA1) and the guilt she feels about her mother created an emotional conflict for her in managing her risks and staying consistent with her sister's narrative frame:

  • Hannah:
  • I've never really wanted to get the test. Sometimes I don't think about it because I feel like if I get it, I just get it. It is what it is. Sometimes I avoid emotional conversations about it, but then I feel selfish about that because my mom never got the opportunity to find that out and if she would have, it would have saved her life. So I feel selfish at times about that too so that's why I just go [to screenings]. But we do try to motivate each other to be on top of that. But nobody's really scared to talk about it too much, so it's just there but we do talk about a little bit but not like too crazy.
  • Helen:
  • Yes, I would tell my sister, you need to get it together, you really need to go [to your screenings]. We both have Aflac cancer policies and so I've been telling her she has to go and she'll remind me and we'll remind each other about trying to get things set up. She just needs to get set up again.
  • Although Hannah felt pressure from the guilt of losing her mother and has her sister frequently checking in, she still had an ‘it is what it is’ attitude about her risks and did not want to actively engage in prevention because she did not want deal with the emotions it brings up. It is also Helen that was driving prevention behaviors while Hannah would prefer to avoid getting screenings because each time it brought back emotional memories. Thus, discrepant frames reflect different coping mechanisms and the tension family storytelling about hereditary cancer can create. Without Helen and her attempts to pull Hannah back into using the empowerment frame, Hannah might further avoid information. Discrepant frames in this dyad did not create or reflect relational conflict, but did reflect the pressure Helen feels to take care of her sister. This was similar for other dyads using discrepant frames, including parent–child dyads when bonds were not so egalitarian. Indeed, when discrepant frames were used in parent–child storytelling, it was often the adult children using an empowerment frame to stress the need to be proactive to a parent using a laissez-faire frame. Throughout families using discrepant frames, members did not have the same interpretation or outlook for their hereditary cancer risks.

    There were also instances when family members using discrepant frames told stories creating relational conflict between family members. Some family members had stopped communicating with one another because a member wanted to avoid receiving risk information, or a member was dismissive of another's health experience. For instance, Ben (husband, 47, no FHH) often talked about believing Betsy's (wife, 46, CHEK2) gene variant was ‘not a problem. It's a red flag’ and not something she should get upset about:

  • Ben:
  • Well, Betsy's hysterectomy stuff is what really got me. When we found out that she had the genes, she's like, ‘I'm going to get a hysterectomy and bla, bla, bla and the doctors were recommending it’. I was like, ‘Wow, that seems like a really drastic thing to do. Like is this the right thing to do?’ I couldn't get that out of my head, but the doctor was like, ‘Listen, if you're not having any more kids’, and we're obviously not, ‘we should have it done’. I mean Betsy was listening and running right head long for that and I was like, ‘Holy shit’. I was like, ‘I can't believe she's going to do this just because they're recommending it’. Then after she had the surgery and she said she got the pathology back and found that she had the precursors [to sarcoma], I was like, ‘Well, I guess they're right’, but man, I could see other people really balking at it.
  • Betsy:
  • I was older. Well, it was like two years ago. I'm 46 or 44 and I can understand someone who is in her late twenties or early thirties, that's so young [to get a hysterectomy]. [The hysterectomy] will save your life. You really need to do it.
  • Ben:
  • I mean the surgery in it of itself is drastic to me. I mean that's-- I would call it highly invasive and then the hormonal problems and everything after that even is like lifelong.
  • Although the doctors found a precursor to sarcoma in Betsy's pathology after her hysterectomy, Ben was not focusing on the surgery as having saved her life. Both family members were talking about the same event, but their narrative tone and frame about Betsy's hysterectomy and medical decisions were different. In this example, Betsy uses an empowerment frame to discuss her risks, which is discrepant from Ben's use of the laissez-faire frame. Betsy and Ben's different outlooks and different forms of coping created some relational problems when Betsy was first learning about her diagnosis and going through her surgery. Overall, Betsy reported receiving little support from her spouse and still deals with intrusive thoughts with little outlet to discuss these feelings at home. Thus, while Betsy might have positive outcomes related to her proactive medical decisions based on her perceptions of risk, the discrepant frames about her hereditary cancer risks reflect and relate to poor coping and add to the couple's relational strain. Among dyads using discrepant frames, stories reflected conflicting risk perceptions and medical choices and relational tension. Often in family narratives fitting the discrepant frames category, family members would dismiss another's point of view, mock a family member's outlook on hereditary cancer risk, and openly discuss not feeling emotionally supported by their family member.

    4 DISCUSSION

    The focus of this study was to examine how family narratives relate to and reflect coping, perceptions of risks, and medical decision-making for families with a FHH of hereditary cancer. Essentially, this study explored the content of family stories of hereditary cancer based on narrative tone and frame. Narrative tone and frames about hereditary cancer gave insight into the individual's psychological well-being, how they understand their risks of developing cancer, and whether the participants engaged in proactive medical decision-making. These relationships are likely bidirectional as tone and frame reflect and are influenced by how well families are coping, how they perceive risks, and the medical choices members have made. Identifying frames and how they relate to health outcomes can help practitioners develop interventions to help families re-frame how they discuss their hereditary cancer risks.

    Families using the empowerment frame reported better emotional coping and more motivation for proactive medical decision-making as these family stories stressed the importance of knowledge to better manage hereditary cancer risks. These families also had an identified pathogenic gene variant, which could contribute to their knowledge and ability to cope as their diagnosis and follow-up recommendations may be clearer compared to at-risk families acting on only a prevalent health history. In contrast, families using an adversity frame had difficulty coping and reported intrusive thoughts about developing cancer, which either motivated them to pursue or avoid preventive medical options. Differences in outcomes from families within the adversity frame category may be related to the degree of perceived threat of hereditary cancer and perceived efficacy in managing hereditary cancer risks (Witte & Allen, 2000). The adversity frame has message components similar to fear appeals that stress the severity of and members’ susceptibility to hereditary cancer. However, the degree to which efficacy is reflected in this narrative frame can explain differences in medical decision-making. Families using the adversity frame who engaged in proactive medical decision-making experienced fear, but their narratives also stressed efficacy regarding members’ ability to prevent or catch cancer early through screenings and surgeries (Witte & Allen, 2000). Thus, practitioners working with patients and families who use an adversity frame should stress the efficacy of genetic counseling, preventive screenings, and prophylactic surgeries to prevent the onset of cancer and mitigate fears. Additionally, genetic counselors also need to provide additional counseling resources such as individual and family therapy recommendations and continued genetic counseling appointments to help these families manage their negative emotions and re-frame their narratives to stress the importance of information and prevention so they may move toward better coping.

    Equally important, family dyads with discrepant frames experienced relational conflict, which limited members’ ability to exchange support and often created tension regarding risk perceptions and the best medical decisions to manage risks. As Werner-Lin and Gardner (2009) found, discrepant family narratives cause challenges for family members regarding how they maintain relationships when there is conflict and how they reconcile multiple perspectives to create shared understanding for medical decision-making. Often family members using a laissez-faire frame communicated emotional distance to hereditary cancer and would downplay another family member's health experience and emotions. Discrepant frames were used both in dyads representing egalitarian bonds such as sisters and spouses and in bonds with hierarchal dynamics such as parents and children. However, parent–child dyads who used discrepant frames in telling their family narrative were composed on middle-aged adults, who may have felt more comfortable challenging a parent's perspective relative to teenage or emerging adult children. However, feeling dismissed or unheard by a family member can motivate an individual to no longer tell their story, which can create rifts among family members and limit communication. Relational conflict and poor emotional support exchange among family members can create coping problems for families with hereditary cancer. Further, previous research shows social support exchange not only decreases anxiety, but also facilitates FHH communication (Ashida et al., 2013; Koehly et al., 2008). Consequently, discrepant frames and the relational conflict they may cause and reflect can inhibit future family communication about hereditary cancer risks. Recommending family therapy can help members better understand why family members frame their story differently and how they can start to overlap their emotional interpretations of the narrative. This type of intervention can aid in both information and emotional support exchange, improving coping and helping members accurately assess and proactively manage their hereditary cancer risks.

    4.1 Practice implications

    Findings from the current study can be used to develop interventions targeting efforts to help families re-frame their narratives to support improved coping, accurate risk perceptions, and proactive medical decision-making. Genetic counselors and practitioners need to be aware of how narrative frames can reflect and influence patients’ and family's health decisions and directly discuss these frames during consultations. Further, these family narratives may reflect the emotionality of the family history if members have lost close relatives, the recency of these losses, where an at-risk individual is in their life span, and their relationship with another family member participating in storytelling. Genetic counselors are well situated to probe into how patients are feeling about their risks and practice narrative medicine, in which practitioners provide patient care with empathy and appreciation for how patient stories affect health (Charon, 2001). By discussing and trying to understand patient stories, genetic counselors can identify what type of resources the patient needs based on the frame they are using.

    Genetic counselors, when counseling patients with a hereditary cancer condition, can provide information about the health condition, risks, and treatment; however, it may be beneficial for genetic counselors to also use the empowerment frame as they are helping patients make sense of a new genetic diagnosis. For instance, as genetic counselors are explaining the implications of genetic testing to patients prediagnosis they can explain how learning more about their potential condition is a way to better manage their health and protect other family members by alerting relatives to their risks. Further, at the time of diagnosis practitioners also need to give patients tools to think more deliberately about how they will frame their story, especially for probands as they are the first to be diagnosed in the family and their story is likely to be particularly impactful (Peterson et al., 2003). Helping patients construct their narrative before leaving the clinic can help patients organize their thoughts and express their emotions in a story that alerts others to risk and equips members to make proactive medical choices.

    These findings also lend themselves to providing practice recommendations in genetic counseling for patients using frames that may reflect poor psychological outcomes and avoidant medical decision-making. For instance, laissez-faire patients need an information intervention that stresses both their risks and what options are available to patients for possibly preventing cancer. As these dyads had not experience a cancer diagnosis or loss in the immediate family, they may not be as emotionally affected by their risk. Within ethical guidelines, counselors can stress patients’ susceptibility to cancer and the severity of their risks while also emphasizing efficacy to help patients move past unemotional acceptance statements (Witte & Allen, 2000). Genetic counselors can also present stories from families using the empowerment frame to help patients using an adversity or laissez-faire frame connect with peer examples of how others cope better by having a sense of control through proactive decision-making. Indeed, patient testimonies and stories can often be a powerful persuasive tool to motivate patients to pursue care (Bekker et al., 2013). Finally, genetic counselors can also help prepare patients for difficult emotions, family conflict, and discrepant frames during FHH conversations. Further, genetic counselors may be well situated to work with multiple family members as relatives often attend genetic counseling sessions together (Gaff, Galvin, & Bylund, 2010). In these situations, genetic counselors can better assess barriers in family communication to provide tailored recommendations to help families share their story, exchange support, and promote prevention efforts.

    4.2 Research recommendations

    The findings of this study present areas for future intervention research and testing. First, families using the laissez-faire frame present a salient challenge as they may be misinformed about their risks and avoidant of discussing hereditary cancer. Future research should examine what resources families may need to re-frame their stories at home when members are not willing to attend clinical consultations. For example, probands often receive a family letter to share with relatives to disclose their test results and alert others to their potential risks. In addition to this family letter, patients may also need conversational tools such as drafting a script with the aid of a genetic counselor to broach this subject with family and create a story that accurately shares medical information. In helping patients intentionally craft their story, genetic counselors can also learn more about other important factors that may influence family narratives and patient risk perceptions and medical decisions. Through this process, providers can more closely examine the temporal nature of narratives about hereditary cancer (Trees, Keonig Kellas, & Roche), as events across the cancer prevention and control continuum such as deaths in the family, movement through the life span, and changing family relationships can alter the family narrative.

    Second, counselors can help patients develop communication strategies for talking with family members who may have discrepant views. Preparing patients for challenges in these family conversations and giving them tailored advice to troubleshoot communication breakdowns can better equip patients to share risk information and exchange support. Developing disclosure and family communication tools can help better prepare patients to have productive family conversations about the FHH and hereditary cancer risks. Developing narrative interventions to help families re-frame hereditary cancer narratives can aid in helping families cope with their lifetime cancer risks and make proactive medical decisions to better manage those risks. Findings from this study also lend themselves to a model of genetic counseling in continued multidisciplinary care, in which genetic counselors continue to counsel and support patients with hereditary disease risks past initial consultations. Although this model may place additional burden on genetic counselors and not be as feasible in areas without readily available access to genetic counselors (Heald et al., 2016), the continued presence of genetic counselors in patient care can help patients receive updated risk information as advances continue in genomic medicine and provide more opportunities for genetic counselors to guide patient care from diagnosis through prevention and possible treatment.

    4.3 Study limitations

    First, although this study presents interesting findings regarding family communication about hereditary cancer, the sample is limited as it is predominantly made up of Caucasian, well-educated participants. These diversity limitations are important to discuss as family is nested within cultural norms, which can influence how relatives discuss health (Bochner, 1976) and their ability to access health resources and services such as genetic counseling (Hall & Olopade, 2005). However, it stands to reason that if the families in this study who have resources face family communication challenges, these problems can be exacerbated in families with limited access to practitioners and information. Second, participants were recruited through advocacy organizations and social media support groups for patients managing hereditary cancers so there may be a selection bias as participants may be more active in managing their risks than the rest of this population (Collier & Mahoney, 1996). However, based on family narrative accounts in which some participants revealed this was a topic they preferred not to think or talk about and/or were uninterested in this topic, selection bias may not have been as prevalent a problem in this exploratory research.

    AUTHOR CONTRIBUTIONS

    Gemme Campbell-Salome was responsible for the conception of the research with advice from Emily Rauscher on the design of the work. Gemme Campbell-Salome collected the interview data. Gemme Campbell-Salome and Emily Rauscher were involved in the analysis of the interview data and drafting and revising the manuscript. Gemme Campbell-Salome has final approval of the version to be published and is accountable for all aspects of the accuracy and integrity of the work.

    ACKNOWLEDGEMENTS

    The research presented in the paper was conducted while the first author was completing a degree and was a part of fulfilling the degree requirements.

      COMPLIANCE WITH ETHICAL STANDARDS

      Conflict of interest

      Gemme Campbell-Salome and Emily Rauscher declare no conflicts of interest.

      Human studies and informed consent

      All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) with the Helsinki Declaration of 1975, as revised in 2000 (5). Informed consent was obtained from all participants for being included in the study.

      Animal studies

      No nonhuman animal studies were carried out by the authors for this article.

      ENDNOTE

    1. 1 Gemme Campbell-Salome would like to dedicate this paper to Dr. Emily A. Rauscher who passed away on September 16, 2019. Emily was my advisor, collaborator, and friend. She believed in this scholarship, provided guidance on the study, and was involved in data analysis and revising the original manuscript. She believed in the important implications it could have for patients and their families. Her advice and support made this research possible. Thank you, Emily.
      • The full text of this article hosted at iucr.org is unavailable due to technical difficulties.